Literature DB >> 27959627

Humanized Mouse Models of Clinical Disease.

Nicole C Walsh1, Laurie L Kenney1, Sonal Jangalwe1, Ken-Edwin Aryee1, Dale L Greiner1, Michael A Brehm1, Leonard D Shultz2.   

Abstract

Immunodeficient mice engrafted with functional human cells and tissues, that is, humanized mice, have become increasingly important as small, preclinical animal models for the study of human diseases. Since the description of immunodeficient mice bearing mutations in the IL2 receptor common gamma chain (IL2rgnull) in the early 2000s, investigators have been able to engraft murine recipients with human hematopoietic stem cells that develop into functional human immune systems. These mice can also be engrafted with human tissues such as islets, liver, skin, and most solid and hematologic cancers. Humanized mice are permitting significant progress in studies of human infectious disease, cancer, regenerative medicine, graft-versus-host disease, allergies, and immunity. Ultimately, use of humanized mice may lead to the implementation of truly personalized medicine in the clinic. This review discusses recent progress in the development and use of humanized mice and highlights their utility for the study of human diseases.

Entities:  

Keywords:  allergy; autoimmunity; cancer; humanized mice; immunodeficient mice; infectious disease; regenerative medicine

Mesh:

Year:  2016        PMID: 27959627      PMCID: PMC5280554          DOI: 10.1146/annurev-pathol-052016-100332

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  153 in total

1.  Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3.

Authors:  Jeremy A Goettel; Subhabrata Biswas; Willem S Lexmond; Ada Yeste; Laura Passerini; Bonny Patel; Siyoung Yang; Jiusong Sun; Jodie Ouahed; Dror S Shouval; Katelyn J McCann; Bruce H Horwitz; Diane Mathis; Edgar L Milford; Luigi D Notarangelo; Maria-Grazia Roncarolo; Edda Fiebiger; Wayne A Marasco; Rosa Bacchetta; Francisco J Quintana; Sung-Yun Pai; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

2.  Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.

Authors:  Renier Myburgh; Sandra Ivic; Michael S Pepper; Gustavo Gers-Huber; Duo Li; Annette Audigé; Mary-Aude Rochat; Vincent Jaquet; Stephan Regenass; Markus G Manz; Patrick Salmon; Karl-Heinz Krause; Roberto F Speck
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.

Authors:  Stephen J Libby; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Michael McClelland; Kelly D Smith; Brad T Cookson; Joyce E Karlinsey; Traci L Kinkel; Steffen Porwollik; Rocio Canals; Lisa A Cummings; Ferric C Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

4.  Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice.

Authors:  Jacqueline Unsinger; Jacquelyn S McDonough; Leonard D Shultz; Thomas A Ferguson; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2009-04-15       Impact factor: 4.962

5.  Assessment of Parasite Liver-Stage Burden in Human-Liver Chimeric Mice.

Authors:  Lander Foquet; Philip Meuleman; Cornelus C Hermsen; Robert Sauerwein; Geert Leroux-Roels
Journal:  Methods Mol Biol       Date:  2015

Review 6.  Visualizing hepatitis C virus infection in humanized mice.

Authors:  Markus von Schaewen; Qiang Ding; Alexander Ploss
Journal:  J Immunol Methods       Date:  2014-03-15       Impact factor: 2.303

7.  Epstein-Barr virus induces erosive arthritis in humanized mice.

Authors:  Yoshikazu Kuwana; Masami Takei; Misako Yajima; Ken-ichi Imadome; Hirotake Inomata; Masaaki Shiozaki; Natsumi Ikumi; Takamasa Nozaki; Hidetaka Shiraiwa; Noboru Kitamura; Jin Takeuchi; Shigemasa Sawada; Naoki Yamamoto; Norio Shimizu; Mamoru Ito; Shigeyoshi Fujiwara
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model.

Authors:  Tomasz Skirecki; Jerzy Kawiak; Eugeniusz Machaj; Zygmunt Pojda; Danuta Wasilewska; Jarosław Czubak; Grażyna Hoser
Journal:  Stem Cell Res Ther       Date:  2015-08-14       Impact factor: 6.832

9.  Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.

Authors:  Ran-Ran Zhang; Yun-Wen Zheng; Bin Li; Tomonori Tsuchida; Yasuharu Ueno; Yun-Zhong Nie; Hideki Taniguchi
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

10.  Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Authors:  Smita Jaiswal; Todd Pearson; Heather Friberg; Leonard D Shultz; Dale L Greiner; Alan L Rothman; Anuja Mathew
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more
  175 in total

1.  Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans.

Authors:  Wan-Rong Wong; Katherine I Brugman; Shayda Maher; Jun Young Oh; Kevin Howe; Mihoko Kato; Paul W Sternberg
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 3.  Mouse models in hematopoietic stem cell gene therapy and genome editing.

Authors:  Stefan Radtke; Olivier Humbert; Hans-Peter Kiem
Journal:  Biochem Pharmacol       Date:  2019-11-06       Impact factor: 5.858

4.  PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.

Authors:  Yan Geng; Xue Liu; Jiurong Liang; David M Habiel; Vrishika Kulur; Ana Lucia Coelho; Nan Deng; Ting Xie; Yizhou Wang; Ningshan Liu; Guanling Huang; Adrianne Kurkciyan; Zhenqiu Liu; Jie Tang; Cory M Hogaboam; Dianhua Jiang; Paul W Noble
Journal:  JCI Insight       Date:  2019-03-21

Review 5.  Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

Authors:  Yoriko Saito; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Trends Immunol       Date:  2020-07-03       Impact factor: 16.687

Review 6.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

Review 7.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Authors:  Adam J Fike; Irina Elcheva; Ziaur S M Rahman
Journal:  Curr Rheumatol Rep       Date:  2019-01-23       Impact factor: 4.592

Review 8.  Long Noncoding RNAs in Host-Pathogen Interactions.

Authors:  Federica Agliano; Vijay A Rathinam; Andrei E Medvedev; Sivapriya Kailasan Vanaja; Anthony T Vella
Journal:  Trends Immunol       Date:  2019-04-30       Impact factor: 16.687

9.  Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.

Authors:  Ayman J Oweida; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Natalie Serkova; Sana D Karam
Journal:  J Vis Exp       Date:  2019-04-22       Impact factor: 1.355

10.  Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Authors:  Carmela Passaro; Quazim Alayo; Isabella De Laura; John McNulty; Korneel Grauwet; Hirotaka Ito; Vivek Bhaskaran; Marco Mineo; Sean E Lawler; Khalid Shah; Maria C Speranza; William Goins; Eric McLaughlin; Soledad Fernandez; David A Reardon; Gordon J Freeman; E Antonio Chiocca; Hiroshi Nakashima
Journal:  Clin Cancer Res       Date:  2018-10-02       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.